Marczyk Elżbieta, Kruczak Anna, Ambicka Aleksandra, Mularz Katarzyna, Harazin-Lechowska Agnieszka, Moskal Julia, Sokołowski Andrzej, Mituś Jerzy, Ryś Janusz
Department of Surgical Oncology, Centre of Oncology Maria Skłodowska-Curie Memorial Institute, Cracow Branch, Poland.
Pol J Pathol. 2011 Dec;62(4):229-35.
Paget disease (PD) of the nipple with coexisting intraductal (DCIS) and invasive carcinoma of the breast comprises 0.6-1.8% of all malignant epithelial neoplasms of this organ. Unlike invasive ductal carcinoma, there are many controversies concerning histological features of PD and the significance of the immunohistochemical characteristics of this neoplasm, which limits the optimal treatment protocols. Therefore, we decided to verify the immunohistochemical markers of PD basing on the retrospective analysis of postoperative material from 69 patients treated surgically. Microscopic examination revealed partial (7 cases) or total (62 cases) replacement of the squamous epithelium of the nipple with nests of atypical glandular cells spreading in an area ranging from 0.2 to 2.5 cm. DCIS coexisting with the PD lesions was present in all examined patients, and infiltrating carcinoma occurred in 31 (44.9%) patients. Both intraepidermal and DCIS components presented c-erbB2 overexpression. Positive estrogen and progesterone receptor staining was observed only in 7 (10.1%) and 2 (2.7%) tumours, respectively. Ki-67 proliferation index of PD cells ranged from 10% to 30%, whereas in DCIS it varied from 4% to 20%. The value of Ki-67 index exceeding 25% in the intraepidermal component of PD was associated with worse overall survival rate.
乳头佩吉特病(PD)合并乳腺导管内癌(DCIS)和浸润性癌占该器官所有恶性上皮性肿瘤的0.6 - 1.8%。与浸润性导管癌不同,关于PD的组织学特征及其免疫组化特征的意义存在许多争议,这限制了最佳治疗方案的制定。因此,我们基于对69例接受手术治疗患者的术后材料进行回顾性分析,来验证PD的免疫组化标志物。显微镜检查显示,乳头鳞状上皮部分(7例)或全部(62例)被非典型腺细胞巢取代,其扩散面积为0.2至2.5厘米。所有接受检查的患者均存在与PD病变共存的DCIS,31例(44.9%)患者发生浸润性癌。表皮内成分和DCIS成分均呈现c-erbB2过表达。仅分别在7例(10.1%)和2例(2.7%)肿瘤中观察到雌激素和孕激素受体染色阳性。PD细胞的Ki-67增殖指数范围为10%至30%,而在DCIS中则为4%至20%。PD表皮内成分中Ki-67指数超过25%与总体生存率较差相关。